retatrutide triple agonist clinical trial Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide, an investigational triple hormone
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20













![Glucagon Like Peptide 1 [7-36] Amide - an overview](https://ars.els-cdn.com/content/image/1-s2.0-S1056872716301696-gr1.jpg)








